IMTXImmatics N.V.
8.930USDMkt Cap: 1.22B $P/E: —3d ago
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developi…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.22B $
Enterprise Value782.11M $
Revenue (TTM)41.70M $
Gross Profit-142.13M $
Net Income (TTM)-196.45M $
Revenue/Share0.3220 USD
Last Price8.930 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees589
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINNL0015285941
Valuation
P/E (Trailing)—
P/E (Forward)-4.22
PEG—
EV/EBITDA-3.59
EV/Revenue18.75
P/S28.02
P/B2.22
EPS (TTM)-1.84
EPS (Forward)-2.03
52W Range
8.60073% of range9.050
52W High9.050 USD
52W Low8.600 USD
Profitability
Gross Margin0.00%
Oper. Margin-734.95%
EBITDA Margin0.00%
Profit Margin-407.01%
ROE-40.58%
ROA-34.93%
Growth
Revenue Growth93.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-176.63M $
CapEx (TTM)6.80M $
FCF Margin-309.56%
FCF Yield-10.58%
Net Debt-378.74M $
Net Debt/EBITDA1.74
Balance Sheet
Debt/Equity0.03
Current Ratio7.54
Quick Ratio7.00
Book Value/Sh3.860 USD
Cash/Share2.895 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.80 USD
Upside (mean)+99.3%
Target Range11.80 USD – 25.00 USD
$11.80+99.3% to mean$25.00
# Analysts6
Ownership
Shares Out.136.67M
Float70.49M
Insiders17.58%
Institutions73.62%
Short Interest
Short Ratio11.8d
Short % Float5.33%
Short % Out.3.68%
Shares Short5.03M
Short (prev mo.)5.41M
Technical
SMA 509.458 (-5.6%)
SMA 20010.03 (-11.0%)
Beta—
S&P 52W Chg21.00%
Avg Vol (30d)601.49K
Avg Vol (10d)462.60K
Technical Indicators
RSI (14)43.9
MACD-0.1223
MACD Signal-0.0682
MACD Hist.-0.0541
BB Upper10.04 USD
BB Middle9.237 USD
BB Lower8.436 USD
BB Width17.34%
ATR (14)0.4797 USD
Vol Ratio (20d)1.20x